Compare GDOT & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GDOT | VALN |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 650.5M | 875.7M |
| IPO Year | 2010 | 2021 |
| Metric | GDOT | VALN |
|---|---|---|
| Price | $10.51 | $10.55 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $11.00 | ★ $15.75 |
| AVG Volume (30 Days) | ★ 452.8K | 17.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $1,723,876,000.00 | N/A |
| Revenue This Year | $22.56 | $2.58 |
| Revenue Next Year | $11.63 | $4.43 |
| P/E Ratio | $31.91 | ★ N/A |
| Revenue Growth | ★ 14.82 | N/A |
| 52 Week Low | $6.59 | $5.43 |
| 52 Week High | $15.41 | $12.25 |
| Indicator | GDOT | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 28.07 | 49.36 |
| Support Level | $10.20 | $8.37 |
| Resistance Level | $11.14 | $12.22 |
| Average True Range (ATR) | 0.33 | 0.40 |
| MACD | -0.10 | -0.10 |
| Stochastic Oscillator | 19.76 | 27.57 |
Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.